All articles by Hemanth Kumar

Hemanth Kumar

EC grants marketing authorisation for GSK’s RSV vaccine Arexvy

Arexvy contains a combination of recombinant glycoprotein F stabilised in the prefusion conformation and GSK’s AS01E adjuvant.

New UK intracellular drug delivery centre to support RNA development

The new centre will provide access to the infrastructure required to accelerate the design, development, and manufacturing of drugs.

University of Sydney will use AI to boost cancer drug research

The university will use the Chemiverse platform to develop novel treatments.

Scientists discover non-invasive approach for cancer therapy

The cost-effective approach is expected to open the doors to treating harder-to-reach cancer types.

MICHR receives grant to accelerate clinical and translational science

The $71m grant will be used to develop scientific and operational innovations in the translational process.

US launches $5bn effort for new Covid-19 vaccines development

The initiative will establish public-private partnerships to expedite the development of next-generation vaccines and treatments.

US Government appeals Texas court ruling on abortion medication

Mifeprex is prescribed to patients who require time-sensitive reproductive care, including care around abortions.

FDA withdraws approval of preterm birth drug Makena

The decision means that the only approved drug to reduce premature birth risk cannot be distributed in interstate commerce.

American Rescue Plan is a watershed moment for US recovery – leading macroeconomic influencers

Economists believe that the $1.9tn stimulus bill passed by the US Congress will pave the way for the US economy to recover.

Top ten pharma companies in 2020

The global pharmaceutical industry is expected to witness positive growth as the top pharma companies are at forefront of the fight against COVID-19.